Skip to main content
SpringerLink
Log in

18F-DOPA PET/CT and neuroendocrine tumours

  • Editorial
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Ezuddin S, Fragkaki C. MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy. Clin Nucl Med 2005;30(8):579–581

    Article  PubMed  Google Scholar 

  2. Kloppel G, Anlauf M. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2005;19(4):507–517

    Article  PubMed  Google Scholar 

  3. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM. The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005;104(11):2292–2309

    Article  PubMed  CAS  Google Scholar 

  4. Ilias I, Shulkin B, Pacak K. New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends Endocrinol Metab 2005;16(2):66–72

    Article  PubMed  CAS  Google Scholar 

  5. Schilling FH, Bihl H, Jacobsson H, Ambros PF, Martinsson T, Borgstrom P, et al. Combined 111In-pentetreotide scintigraphy and 123I-mIBG scintigraphy in neuroblastoma provides prognostic information. Med Pediatr Oncol 2005;35:688–691

    Article  Google Scholar 

  6. Reed NS. Management of neuroendocrine tumours. Clin Oncol (R Coll Radiol) 1999;11(5):295–302

    CAS  Google Scholar 

  7. Pearse AG. The diffuse neuroendocrine system: peptides, amines, placodes and the APUD theory. Prog Brain Res 1986;68:25–31

    Article  PubMed  CAS  Google Scholar 

  8. Ahlstrom H, Eriksson B, Bergstrom M, Bjurling P, Langstrom B, Oberg K. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995;195(2):333–337

    PubMed  CAS  Google Scholar 

  9. Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001;220(2):373–380

    PubMed  CAS  Google Scholar 

  10. Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, et al. Pheochromocytomas: detection with 18F DOPA whole body PET—initial results. Radiology 2002;222(2):507–512

    Article  PubMed  Google Scholar 

  11. Hoegerle S, Ghanem N, Altehoefer C, Schipper J, Brink I, Moser E, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30(5):689–694

    Article  PubMed  CAS  Google Scholar 

  12. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005;4(1):61–68

    Article  PubMed  CAS  Google Scholar 

  13. Hoegerle S, Ghanem N, Altehoefer C, Schipper J, Brink I, Moser E, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30:689–694

    Article  PubMed  CAS  Google Scholar 

  14. Hoegerle S, Altehoefer C, Ghanem N, Brink I, Moser E, Nitzsche E. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001;28:64–71

    Article  PubMed  CAS  Google Scholar 

  15. Gourgiotis L, Sarlis NJ, Reynolds JC, Vanwaes C, Merino MJ, Pacak K. Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab 2003;88(2):637–641

    Article  PubMed  CAS  Google Scholar 

  16. Jacob T, Grahek D, Younsi N, Kerrou K, Aide N, Montravers F, et al. Positron emission tomography with [18F]FDOPA and [18F]FDG in the imaging of small cell lung carcinoma: preliminary results. Eur J Nucl Med Mol Imaging 2003;30:1266–1269

    Article  PubMed  CAS  Google Scholar 

  17. Koopmans KP, Brouwers AH, De Hooge MN, Van der Horst-Schrivers AN, Kema IP, Wolffenbuttel BH, et al. Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid. J Nucl Med 2005;46:1240–1243

    PubMed  Google Scholar 

  18. Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, et al. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med 2005;46:62S–66S

    PubMed  CAS  Google Scholar 

  19. Wild D, Mäcke HR, Waser B, Reubi JC, Ginj M, Rasch H, et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging 2005;32(6):724

    Article  PubMed  Google Scholar 

  20. Wild D, Schmitt JS, Ginj M, Mäcke HR, Bernard BF, Krenning E, et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals. Eur J Nucl Med Mol Imaging 2003;30:1338–1347

    Article  PubMed  CAS  Google Scholar 

  21. Ginj M, Chen J, Walter MA, Eltschinger V, Reubi JC, Maecke HR. Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. Clin Cancer Res 2005;11(3):1136–1145

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Service - PET Unit, Policlinico S. Orsola-Malpighi, Bologna University,, Bologna, Italy

    Cristina Nanni & Stefano Fanti

  2. Nuclear Medicine Service - PET Unit, S. Maria della Misericordia Hospital, Istituto Oncologico Veneto (IOV), Viale Tre Martiri, 140, 45100, Rovigo, Italy

    Domenico Rubello

Authors
  1. Cristina Nanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Domenico Rubello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefano Fanti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Rubello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nanni, C., Rubello, D. & Fanti, S. 18F-DOPA PET/CT and neuroendocrine tumours. Eur J Nucl Med Mol Imaging 33, 509–513 (2006). https://doi.org/10.1007/s00259-006-0079-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-006-0079-5

Search

Navigation